Spots Global Cancer Trial Database for Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
Official Title: Open Comparative Study With a Cross-over According to Patients'Preference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-rectal Cancer
Study ID: NCT00905047
Conditions
Study Description
Brief Summary: The scope of the trial is to determine the preference of patients, after randomization and cross-over, for one of the two treatments. Another objective of the trial is to assess and compare the safety of each treatment.
Detailed Description: Further study details as provided by Centre Oscar Lambret.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre Paul Papin, Angers, , France
Centre Hospitalier, Armentieres, , France
Centre Hospitalier de Béthune, Beuvry, , France
Centre Hospitalier de CHOLET, Cholet, , France
Centre Leonard de Vinci, Dechy, , France
Polyclinique du Bois, Lille, , France
Centre Oscar Lambret, Lille, , France
Hopital Saint Vincent de Paul, Lille, , France
Centre Hospitalier Regional, Lille, , France
Centre Hospitalier, Roubaix, , France
Centre Joliot-Curie, Saint Martin les Boulogne, , France
Centre Hospitalier, Valenciennes, , France
Clinique des Dentellieres, Valenciennes, , France
Contact Details
Name: ADENIS Antoine, MD,PhD
Affiliation: Centre Oscar Lambret
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
